Skip Navigation
Skip to contents

KDDW 2023


Abstract Submission

Home    >    Submission    >    Abstract Submission
Abstract Submission Deadline: September 13, 2023

※ If your abstract is accepted to KDDW 2023, it will be published in a supplement of Gut and Liver.

Important Date

Abstract Submission Deadline / Sep 30, 2023 / Abstract Acceptance Notification / Oct 24, 2023 / Presenter Registration Deadline / Oct 30, 2023

The Scientific Committee of KDDW 2023 cordially invites you to submit abstracts. Abstracts should be submitted online via abstract submission system through the website no later than deadline.
Submitted abstracts can be revised on the website during the abstract submission period. And submitted abstracts will be reviewed by the Scientific Program Committee.

Please read the guidelines carefully before submitting your abstract.

Presentation Type

  • - Oral Presentation
  • - E-poster

* Authors may choose their presentation preference. However, the Scientific Committee will make the final decision after review.

Abstract Topics

Functional GI disorders/Motility
  • GERD
  • Functional dyspepsia
  • Irritable bowel syndrome
  • Constipation
  • Basic
  • Microbiota
  • Surgery
  • Pediatrics
  • Others
Upper GI
  • Issues on H. pylori
  • Peptic ulcer disease
  • Upper GI tract malignancies : Esophagus, Stomach, Duodenum
  • Surgery
  • Pediatrics
  • Endoscopy
  • Others
Lower GI
  • Inflammatory bowel disease
  • Colorectal neoplasia
  • Small bowel diseases
  • Microbiota & nutrition
  • Surgery
  • Pediatrics
  • Endoscopy
  • Others
Liver
  • Basic
  • Viral hepatitis B
  • Viral hepatitis C and Others
  • Alcoholic and non-alcoholic fatty liver diseases
  • Cirrhosis and related complications
  • HCC
  • Surgery
  • Others
Oncology
  • Basic/Translational
  • Esophagus/Stomach
  • Colon/Rectum
  • Biliary tract/Pancreas
  • Surgery
  • Pediatrics
  • Endoscopy
  • Others
Pancreatobiliary
  • Cholestasis and gallstone
  • Biliary tract cancer
  • Pancreatitis
  • Pancreatic cancer
  • Endoscopy and imaging
  • Surgery
  • Pediatrics
  • Others
Others
  • Gender-specific medicine
  • Others

Abstract Submission Guidelines

  1. Step 1. Fill out Abstract Title
  2. Step 2. Choose presentation type & Submission type & Topic category
  3. Step 3. Fill out the presenting author information
  4. Step 4. Fill out the co-authors’ information
  5. Step 5. Fill out abstract details
  6. Step 6. Review and submit

Please follow these guidelines carefully

  • Abstracts should be no more than 300 words. Word count only includes the text body of your abstract.
  • All abstracts should be written in English, including the title, abstract text, names of the authors, affiliations, and table, figure, or graph.
  • Authors may edit and modify submitted abstracts until the submission deadline. It is the responsibility of the authors to ensure the accuracy of the abstract. There will be no additional editing after the deadline.
  • It is the responsibility of the authors to ensure that their text does not contain typos or grammatical errors.
  • A confirmation letter of abstract will be automatically sent to the submitter, presenting author and corresponding author by e-mail upon completion of on-line submission. The contact details you provide must coincide with those of the presenting author and corresponding author, Otherwise the presenter will not receive important information about the allocated session(s).
    If there is no confirmation letter after abstract submission, please contact the secretariat, kddwinfo@medioffice.or.kr
  • Presenting authors must register for the conference through the website by October 20 (Fri), 2023
  • Abstracts should be submitted in English even if the session is in Korean. Session details will be informed later with the acceptance notice of your submitted abstract.
  • Case report can also be submitted.

Notification of Acceptance

  • All submitted abstracts will be reviewed by the Scientific Committee according to reviewing procedures.
  • Notification of acceptance will be sent by e-mail to corresponding, presenting and abstract submitting authors.

Withdrawal of Abstract

  • If the presenting author of an accepted abstract does not register by October 20 (Fri), 2023, the abstract will be automatically withdrawn from the final program.
  • If you have to withdraw an abstract, please notify the secretariat (kddwinfo@medioffice.or.kr) in writing as soon as possible.
Supported by Member Societies
Associated Society
Supported by
Endorsed By
Diamond
Platinum
Gold
  • Silver
    Bronze+
    • 동아에스티
    Bronze
    • 길리어드
    • 유한양행
    • 삼성바이오에피스
    • 셀트리온제약(바이오마케팅팀)
    Sapphire+
    • 제일약품
    Sapphire
    • 일동제약
    • 한국에브비
    • 대원제약
    Crystal
    • BMS
    • 부광약품
    • 한미약품
    • 삼일제약
    • 종근당
    Pearl
    • 보령
    • SK케미칼
    • 녹십자웰빙
    • 안국약품
    • 유나이티드
    • 태준제약
    • 펜탁스메디컬
    • 건강약품
    • 에르베메디칼
    • 엠아이텍
    • 중외제약
    • 한국에자이
    • 일양약품
    • 스탠다드싸이텍
    • (주)한국로슈
    • 한국메나리니
    • 명문제약
    • 아이넥스코퍼레이션
    • GC녹십자
    • 조양메디컬
    • Naturlax
    • 파인메딕스
    • 하나제약

    Go to Top

    케이디디더블유 운영협의체

    Business License No.: 609-82-84671

    President: Jae Gyu Kim

    Tel.: 02-459-8252

    E-mail : kddwoffice@gmail.com

    Address : Room 305 Lotte Gold Rose Ⅱ, 31 Seolleung-ro 86 gil, Gangnam-gu, Seoul, 06193, Korea
    KDDW 2023 Secretariat
    Contact (Scientific Program & Abstract) kddwinfo@medioffice.or.kr
    (Registration & Sponsor) Email.kddw2023@medioffice.or.kr